Amenta, Francesco

Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease.

Marucci, G., Buccioni, M., Ben, D. D., Lambertucci, C., Volpini, R., & Amenta, F. (2021) · Neuropharmacology

Cholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments

Cited by 1,147

Telemedicine practice: Review of the current ethical and legal challenges

Nittari, G., Khuman, R., Baldoni, S., Pallotta, G., Battineni, G., Sirignano, A., Amenta, F., & Ricci, G. (2020) · Telemedicine and e-Health

Telemedicine and Telehealth ImplementationMedical and Health Sciences Research

Cited by 471

The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer’s disease with cerebrovascular injury: interim results.

Amenta, F., Carotenuto, A., Fasanaro, A. M., Rea, R., & Traini, E. (2012) · Journal of the Neurological Sciences

Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

Cited by 52

The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer’s Disease) trial: interim results after two years of treatment.

Amenta, F., Carotenuto, A., Fasanaro, A. M., Rea, R., & Traini, E. (2014) · Journal of Alzheimer s Disease

Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

Cited by 50

Late and early onset dementia: What is the role of vascular factors? A retrospective study

Carotenuto, A., Rea, R., Colucci, L., Ziello, A. R., Molino, I., Carpi, S., Traini, E., Amenta, F., & Fasanaro, A. M. (2012) · Journal of the Neurological Sciences

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 27

A Review on Barriers to Sustainable Telemedicine Implementation in Ethiopia

Sagaro, G. G. G., BATTINENI, G., & AMENTA, F. (2019) · Research Square

Telemedicine and Telehealth ImplementationElectronic Health Records Systems

Cited by 5